Answers are grounded in this paper and cite their sources.
Robust animal models and quantitative, replicable biomarkers of neural dysfunction are needed to decrease risk and enable successful drug discovery and development for ASD and other neurodevelopmental disorders. Complementary to the replicated behavioral phenotypes of the Shank3B mutant mouse is the new identification of a robust, translational in vivo neurophysiological phenotype. Our findings provide strong evidence for robustness and replicability of key translational phenotypes in Shank3B mutant mice and support the usefulness of this mouse model of ASD for therapeutic discovery.
No takes yet. Share an insight, caveat, or question.
Dhamne et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: